Skip to main content
Scope Fluidics S.A. logo

Scope Fluidics S.A. — Investor Relations & Filings

Ticker · SCP ISIN · PLSCPFL00018 LEI · 259400EUNFX4E2BEHU15 WAR Professional, scientific and technical activities
Open in API
Filings indexed 518 across all filing types
Latest filing 2023-03-15 Investor Presentation
Country PL Poland
Listing WAR SCP

About Scope Fluidics S.A.

https://scopefluidics.com/

Scope Fluidics S.A. is a biotechnology company that develops innovative medical diagnostic solutions based on microfluidic technologies. The company's business model involves incubating projects within special-purpose vehicles (SPVs) with the goal of selling them to global strategic partners. Its primary project, developed by its subsidiary Bacteromic Sp. z o.o., is the BACTEROMIC system. This automated system provides rapid, comprehensive antimicrobial susceptibility testing (AST) to address the challenge of antibiotic resistance. Previously, the company developed the PCR|ONE system for rapid molecular diagnostics through its Curiosity Diagnostics SPV, which was acquired by Bio-Rad in 2022. The company focuses on creating fast, effective, and accessible diagnostic tools to improve healthcare outcomes.

Recent filings

Filing Released Lang Actions
Strategia Rozwoju Scope Fluidics
Investor Presentation Classification · 95% confidence The document is titled "Strategia Rozwoju Scope Fluidics" (Scope Fluidics Development Strategy) and outlines long-term strategic goals (until 2033), key vectors for development (BacterOMIC technology, creation of 'Scope Discovery' organization), and financing plans. This content describes the company's future direction, business model, and strategic objectives, which aligns best with a high-level strategic document. It is not a standard regulatory filing like a 10-K, an earnings release (ER), or a quarterly report (IR). It functions as a comprehensive strategic plan presentation or document. Given the options, the closest fit for a detailed, forward-looking strategic plan document that is not a standard financial report is often categorized as an Investor Presentation (IP) or sometimes a specialized Management Report (MDA) if it contains significant management commentary on strategy. Since it details the core business strategy, technology development timelines, and exit strategies (transactions), 'Investor Presentation' (IP) is the most appropriate classification for this type of forward-looking strategic disclosure aimed at investors, even though it might not be a slide deck format. It is a detailed strategic document.
2023-03-15 Polish
Strategia Rozwoju Scope Fluidics - Content (PL)
Management Reports Classification · 99% confidence The document text is very short (949 characters) and appears to be an official announcement from the Management Board ('Zarząd') of Scope Fluidics S.A. It details the approval of the 'Strategia Rozwoju' (Development Strategy) by the Supervisory Board ('Rada Nadzorcza') and mentions that the Strategy is attached as an appendix ('załącznik do niniejszego raportu'). This structure—a brief announcement stating that a significant document (the Strategy) has been finalized and is attached—strongly suggests this is an announcement about the publication of information rather than the full strategy document itself. Since 'Strategy' documents are not explicitly listed, we must look for the closest fit. Given the content relates to future plans and strategic direction, it is most closely related to Investor Presentation (IP) or Management Reports (MDA). However, the primary function here is announcing the finalization and attachment of a key document. Following Rule #2 (The 'MENU VS MEAL' Rule), if a short document announces that a report is attached, it should be classified as a Report Publication Announcement (RPA).
2023-03-15 Polish
Informacja o warunkowej decyzji Państwowego Urzędu Własności Intelektualnej Chin o przyznaniu spółce Bacteromic patentu na chip mikroprzepływowy - Content (PL)
Regulatory Filings Classification · 99% confidence The document is a short announcement (1595 characters) from a Polish company (Zarząd Scope Fluidics) regarding a conditional patent grant decision from the Chinese State Intellectual Property Office for a subsidiary (Bacteromic). It details the implications of the patent (exclusivity in China for microfluidic chips) and mentions ongoing efforts to secure a US patent. Since this is a specific, material event announcement that doesn't fit the definitions for ER, IR, 10-K, or specific corporate actions (like DIV, SHA, DIRS), and it is not an announcement *about* a report (RPA), it falls best under the general 'Regulatory Filings' category (RNS) as a miscellaneous regulatory/material event disclosure, common for non-SEC filings.
2023-03-03 Polish
Sprawozdanie RN za 2022
Governance Information Classification · 95% confidence The document is titled "SPRAWOZDANIE RADY NADZORCZEJ SCOPE FLUIDICS S.A. Z SIEDZIBĄ W WARSZAWIE za okres od dnia 1 stycznia 2022 roku do dnia 31 grudnia 2022 roku" (Report of the Supervisory Board of Scope Fluidics S.A. for the period from January 1, 2022, to December 31, 2022). It details the Supervisory Board's assessment of the financial statements, the management report, the proposal for profit distribution, and a report on the Supervisory Board's own activities, referencing specific articles of the Polish Commercial Companies Code (KSH). This content strongly aligns with the requirements for a comprehensive annual report or a specific governance/oversight report related to the annual cycle. Given the detailed assessment of the annual financial statements (Section 2) and the management report (Section 3), and the fact that it is a formal report from the Supervisory Board covering the entire fiscal year, it is most closely related to the governance and oversight aspects typically included in or accompanying the Annual Report (10-K equivalent in structure, though Polish specific). However, since the definitions provided include 'Audit Report / Information (AR)' for standalone audit reports and 'Governance Information (CGR)' for internal rules/board structure, and this document is explicitly the *Supervisory Board's Report* which includes governance oversight, financial statement review, and profit distribution review, it fits best under a category related to comprehensive annual oversight/governance reporting. Since it is a detailed report covering the entire year's oversight and assessment of the annual results, and not just a brief announcement, it is not RPA or RNS. It is more comprehensive than a typical 'Governance Information (CGR)' which usually focuses on structure/rules, as this document reviews the *past year's* performance assessment. In the context of the provided codes, 'AR' (Audit Report / Information) is for standalone audit reports, which this is not (it's the Board's report *on* the audit). '10-K' is for the official yearly report, which this document is a critical component of, but not the full financial filing itself. Given the focus on the Board's activities, governance review, and assessment of management reports and financials for the year, 'CGR' (Governance Information) is a strong candidate, but 'AR' (Audit Report / Information) sometimes encompasses broader oversight reports in some contexts, though less likely here. Considering the document is a formal, detailed report from the Supervisory Board reviewing the entire year's financial and operational governance, it is a key governance document. If we must choose the closest fit among the options, and recognizing that this is a Polish statutory report reviewing the annual results and governance structure/oversight, it is a comprehensive governance/oversight document. Since it reviews the financial statements and management report, it is highly related to the annual cycle. Given the options, and its focus on the Board's oversight role and assessment of the annual results and governance compliance, 'CGR' (Governance Information) is the most appropriate fit among the specific governance/oversight codes, as it details the Board's activities and oversight functions for the year.
2023-02-20 Polish
Wniosek Zarządu do ZWZ w sprawie podziału zysku za 2022
AGM Information Classification · 98% confidence The document is titled 'Wniosek Zarządu Scope Fluidics S.A. do Zwyczajnego Walnego Zgromadzenia Scope Fluidics S.A. dotyczący podziału zysku za 2022 rok' (Management Board Proposal to the Annual General Meeting regarding the distribution of profit for 2022). It explicitly details the proposed allocation of the 2022 profit, including amounts for covering past losses, allocation to reserve capital, and the proposed dividend amount per share, along with the record date and payment date. This content is directly related to the agenda and decisions made at an Annual General Meeting (AGM) concerning profit distribution. While it involves dividend details (DIV), the context is a formal proposal presented *to* the AGM, making AGM-R the most appropriate classification for the meeting materials/proposals.
2023-02-20 Polish
Projekty uchwał na ZWZ
AGM Information Classification · 99% confidence The document text consists of multiple numbered resolutions ('UCHWAŁA NR 1', 'UCHWAŁA NR 2', etc.) passed by the 'Zwyczajnego Walnego Zgromadzenia' (Ordinary General Meeting) of Scope Fluidics S.A. on March 20, 2023. The agenda items explicitly cover the approval of annual reports (for the year ending December 31, 2022), dividend distribution, and granting of discharge (absolutorium) to management and supervisory board members. These are the core activities documented in the minutes or resolutions of an Annual General Meeting (AGM). Therefore, the document type is AGM Information (AGM-R).
2023-02-20 Polish

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.